Eutilex: Clinical Trials

4 unknown. 4 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	4	Unknown 4
Phase 2	2	Unknown 2

Follow Eutilex: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307 EU307 CAR-T Cell - Advanced Hepatocellular Carcinoma	Phase 1	Unknown	Eutilex	12	2023-08-24	2024-03-15
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy EU103 - Solid Tumor	Phase 1	Unknown	Eutilex	15	2023-08-08	2024-03-13
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors EU101 - Solid Tumor, Renal Cell Cancer Metastatic	Phase 1 / Phase 2	Unknown	Eutilex	110	2021-05-31	2024-03-15
A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies EBViNT Cell - EBV Associated Extranodal NK/T-cell Lymphoma, EBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma	Phase 1 / Phase 2	Unknown	Eutilex	72	2018-12-14	2022-07-11

Conditions studied

Adenocarcinoma Of Esophagus (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Lymphoma (1)  ·  Prostatic Neoplasms (1)  ·  Stomach Neoplasms (1)

Countries

South Korea (4)  ·  United States (1)

Top investigators

Ho Jin Shin, MD (1)  ·  Hyeon Seok Eom, MD (1)  ·  Jeeyun Lee, MD (1)  ·  Min-hee Ryu, MD (1)  ·  Minsuk Kwon, MD (1)  ·  Won Seog Kim, MD (1)  ·  Won Sik Lee, MD (1)

Results publications

PMID 38172595